Literature DB >> 6036279

Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy.

R V Shearer, E L Dubois.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6036279     DOI: 10.1016/0002-9394(67)92518-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  21 in total

1.  Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Jasmine W S Ngai; Wai-Man Chan; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2006-06-28       Impact factor: 2.379

2.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

3.  Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.

Authors:  Paul Salu; André Uvijls; Pierre van den Brande; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2010-04-16       Impact factor: 2.379

Review 4.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

Review 5.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

6.  Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine.

Authors:  J M Rhodes; J E McLaughlin; D J Brown; L A Nuttall; D P Jewell
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

7.  Assessing hydroxychloroquine toxicity by the multifocal ERG.

Authors:  Michael N Moschos; Marilita M Moschos; Michael Apostolopoulos; John A Mallias; Christos Bouros; George P Theodossiadis
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

8.  Ocular changes resulting from therapy with amiodarone.

Authors:  D V Ingram; N S Jaggarao; D A Chamberlain
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

Review 9.  Ocular complications associated with systemic medications used in allergy/immunology practice.

Authors:  Avinash Gurbaxani; Clare L Fraser; Simon E Skalicky; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

10.  Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquine.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.